69 related articles for article (PubMed ID: 34105174)
1. A patient-focused survey to assess the effects of the COVID-19 pandemic and social guidelines on people with muscular dystrophy.
Eichinger K; Lewis L; Dilek N; Higgs K; Walker M; Palmer D; Cooley JM; Johnson N; Tawil R; Statland J
Muscle Nerve; 2021 Sep; 64(3):321-327. PubMed ID: 34105174
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of conservative non-pharmacological interventions in people with muscular dystrophies: a systematic review and meta-analysis.
Leone E; Pandyan A; Rogers A; Kulshrestha R; Hill J; Philp F
J Neurol Neurosurg Psychiatry; 2024 Apr; 95(5):442-453. PubMed ID: 38124127
[TBL] [Abstract][Full Text] [Related]
3. Living with facioscapulohumeral muscular dystrophy during the first two COVID-19 outbreaks: a repeated patient survey in the Netherlands.
Deenen JCW; Kools J; Greco A; Thewissen R; van de Put W; Lanser A; Joosten LAB; Verbeek ALM; van Engelen BGM; Voermans NC
Acta Neurol Belg; 2024 Apr; 124(2):559-566. PubMed ID: 38218752
[TBL] [Abstract][Full Text] [Related]
4. Self-reported physical activity in people with limb-girdle muscular dystrophy and Charcot-Marie-Tooth disease in Norway.
Andries A; van Walsem MR; Frich JC
BMC Musculoskelet Disord; 2020 Apr; 21(1):235. PubMed ID: 32284057
[TBL] [Abstract][Full Text] [Related]
5. Self-reported reduced sleep quality and excessive daytime sleepiness in facioscapulohumeral muscular dystrophy.
Hoffmann HM; Malo-Juvera V; Statland JM
Muscle Nerve; 2022 Oct; 66(4):487-494. PubMed ID: 35893768
[TBL] [Abstract][Full Text] [Related]
6. Social distancing during the COVID-19 pandemic: quantifying the practice in Michigan - a "hotspot state" early in the pandemic - using a volunteer-based online survey.
Cassidy-Bushrow AE; Baseer M; Kippen K; Levin AM; Li J; Loveless I; Poisson LM; Schultz L; Wegienka G; Zhou Y; Johnson CC
BMC Public Health; 2021 Jan; 21(1):245. PubMed ID: 33514350
[TBL] [Abstract][Full Text] [Related]
7. If you build a rare disease registry, will they enroll and will they use it? Methods and data from the National Registry of Myotonic Dystrophy (DM) and Facioscapulohumeral Muscular Dystrophy (FSHD).
Hilbert JE; Kissel JT; Luebbe EA; Martens WB; McDermott MP; Sanders DB; Tawil R; Thornton CA; Moxley RT;
Contemp Clin Trials; 2012 Mar; 33(2):302-11. PubMed ID: 22155025
[TBL] [Abstract][Full Text] [Related]
8. Frequency of reported pain in adult males with muscular dystrophy.
Jacques MF; Stockley RC; Bostock EI; Smith J; DeGoede CG; Morse CI
PLoS One; 2019; 14(2):e0212437. PubMed ID: 30763387
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 social distancing: negative effects on people with Parkinson disease and their associations with confidence for self-management.
Yogev-Seligmann G; Kafri M
BMC Neurol; 2021 Jul; 21(1):284. PubMed ID: 34284733
[TBL] [Abstract][Full Text] [Related]
10. The Impact of COVID-19 on Families With Pediatric Muscular Dystrophy Patients.
Zubair AS; Scharer K; Lembeck P; Ionita C; Roy B
Cureus; 2023 Jun; 15(6):e41138. PubMed ID: 37519528
[TBL] [Abstract][Full Text] [Related]
11. The Impact of COVID-19 on Patients With Cancer: A National Study of Patient Experiences.
Rodriguez GM; Ferguson JM; Kurian A; Bondy M; Patel MI
Am J Clin Oncol; 2021 Nov; 44(11):580-587. PubMed ID: 34519677
[TBL] [Abstract][Full Text] [Related]
12. Let's (not) get together! The role of social norms on social distancing during COVID-19.
Martínez D; Parilli C; Scartascini C; Simpser A
PLoS One; 2021; 16(3):e0247454. PubMed ID: 33651809
[TBL] [Abstract][Full Text] [Related]
13. Changes in social connection during COVID-19 social distancing: It's not (household) size that matters, it's who you're with.
Okabe-Miyamoto K; Folk D; Lyubomirsky S; Dunn EW
PLoS One; 2021; 16(1):e0245009. PubMed ID: 33471811
[TBL] [Abstract][Full Text] [Related]
14. Health checkups during the pandemic and clinical impact of COVID-19 in children with neuromuscular disease.
Fernández Sardá MS; Dicembrino M; Aguerre V
Arch Argent Pediatr; 2024 Jun; 122(3):e202310214. PubMed ID: 38078893
[TBL] [Abstract][Full Text] [Related]
15. Psychological Distancing Usage Uniquely Predicts Reduced Perceived Stress During the COVID-19 Pandemic.
Dicker EE; Jones JS; Denny BT
Front Psychol; 2022; 13():838507. PubMed ID: 35250780
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD).
Ducharme-Smith A; Nicolau S; Chahal CAA; Ducharme-Smith K; Rehman S; Jaliparthy K; Khan N; Scott CG; St Louis EK; Liewluck T; Somers VK; Lin G; Brady PA; Milone M
Front Neurol; 2021; 12():668180. PubMed ID: 34108930
[No Abstract] [Full Text] [Related]
17. SMCHD1's ubiquitin-like domain is required for N-terminal dimerization and chromatin localization.
Gurzau AD; Horne CR; Mok YF; Iminitoff M; Willson TA; Young SN; Blewitt ME; Murphy JM
Biochem J; 2021 Jul; 478(13):2555-2569. PubMed ID: 34109974
[TBL] [Abstract][Full Text] [Related]
18. CRISPR mediated targeting of DUX4 distal regulatory element represses DUX4 target genes dysregulated in Facioscapulohumeral muscular dystrophy.
Das S; Chadwick BP
Sci Rep; 2021 Jun; 11(1):12598. PubMed ID: 34131248
[TBL] [Abstract][Full Text] [Related]
19. N-of-1 trial of salbutamol in hyperkalaemic periodic paralysis.
Stunnenberg BC; Merkus EC; Raaphorst J; Saris CG; Groenewoud H; Statland J; Weijma R; van Vlijmen B; Griggs R; van Engelen BGM; van der Wilt GJ
J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1352-1353. PubMed ID: 34112717
[No Abstract] [Full Text] [Related]
20. A Journey with LGMD: From Protein Abnormalities to Patient Impact.
Georganopoulou DG; Moisiadis VG; Malik FA; Mohajer A; Dashevsky TM; Wuu ST; Hu CK
Protein J; 2021 Aug; 40(4):466-488. PubMed ID: 34110586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]